Tactile Systems Technology, Inc. reported a revenue of $329.5 million for the fiscal year ending December 31, 2025, marking a 12% increase from $293.0 million in 2024. The company's net income also rose to $19.1 million, up from $17.0 million in the previous year. This growth was primarily driven by a 7% increase in sales and rentals of lymphedema products, which accounted for 84% of total revenue, and a significant 52% increase in sales of the airway clearance product line, AffloVest, which contributed 16% to total revenue.

The company experienced notable changes in its operational structure, including an increase in its workforce. As of December 31, 2025, Tactile employed 1,086 individuals, up from 1,051 in 2024. The sales and marketing expenses rose by 8% to $121.2 million, reflecting investments in expanding the commercial infrastructure and enhancing clinician awareness of its lymphedema solutions. Additionally, the company reported a 25% increase in reimbursement, general, and administrative expenses, totaling $88.7 million, largely due to increased personnel-related compensation and IT-related expenses.

Tactile Systems continued to focus on strategic developments, including the launch of its second-generation Entre Plus system in March 2023 and the Nimbl system in October 2024. The company also acquired the AffloVest product line in September 2021, which has since shown strong revenue growth. The company’s direct-to-patient and -provider model has allowed it to engage effectively with both patients and clinicians, which is critical for driving product adoption and reimbursement success. As of December 31, 2025, Tactile served over 84,000 patients with its compression therapy devices, bringing the cumulative total to over 635,000 since launch.

Looking ahead, Tactile Systems Technology anticipates continued revenue growth driven by increased awareness of its products, expansion of its sales force, and enhanced marketing efforts. However, the company also faces potential challenges, including pricing pressures from private insurers and the impact of changes in Medicare coverage criteria. The company is committed to maintaining its competitive edge through ongoing innovation and strategic partnerships, while also navigating the complexities of the healthcare reimbursement landscape.

About TACTILE SYSTEMS TECHNOLOGY INC

Tactile Systems Technology, Inc. develops and markets medical devices for treating underserved chronic diseases such as lymphedema, chronic venous insufficiency, and respiratory conditions. Its core products include pneumatic compression systems and airway clearance devices, primarily sold through direct-to-patient and provider models. The company leverages clinical evidence, reimbursement strategies, and a scalable home care platform to improve patient outcomes and reduce healthcare costs.

This description was generated via AI from an annual report. Updated 9 months ago.

About 10-K Filings

A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.

Key points about the 10-K:

  • Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
  • Content: It includes:
    • Detailed financial statements audited by an independent accounting firm
    • Management's Discussion and Analysis (MD&A) of financial condition and results
    • Description of the company's business, properties, and legal proceedings
    • Risk factors and market risks
    • Executive compensation and corporate governance information
  • Importance: Considered the most comprehensive and important document a public company files with the SEC.
  • Length: Often exceeds 100 pages due to its extensive and detailed nature.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.